A bundle of healthcare legislation that would introduce greater oversight of the pharmacy benefit manager (PBM) sector is ...

The FDA has approved Neurocrine Bioscience's Crenessity for classic congenital adrenal hyperplasia (CAH), the first drug for ...

Recruiting for clinical trials is hard… and expensive. And a large component of that time involves people sifting through ...

Novo Nordisk has started building its first brand-new manufacturing facility in Denmark since the millennium, saying it plans ...

Dermatology specialist Galderma has claimed a second FDA approval for IL-31 inhibitor Nemluvio, adding atopic dermatitis to ...

In a time when pharmaceutical companies no longer have the economic luxury of decades-long development cycles, indication ...

Essentially, what Concr demonstrates is that training their algorithms on smaller, yet more diverse, data can lead to increased accuracy, due to the broader biological variability within that training ...

The analysis found that across all the 339 appraisals carried out for the new medicines, the median gain in quality-adjusted ...